Compare PULM & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PULM | DTSS |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6M | 10.9M |
| IPO Year | N/A | N/A |
| Metric | PULM | DTSS |
|---|---|---|
| Price | $2.60 | $1.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.6K | ★ 117.6K |
| Earning Date | 10-16-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,000.00 | ★ $64,349,277.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $134.88 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 68.56 |
| 52 Week Low | $2.15 | $0.64 |
| 52 Week High | $10.40 | $3.10 |
| Indicator | PULM | DTSS |
|---|---|---|
| Relative Strength Index (RSI) | 45.14 | 58.33 |
| Support Level | $2.23 | $0.79 |
| Resistance Level | $2.70 | $0.92 |
| Average True Range (ATR) | 0.16 | 0.12 |
| MACD | 0.12 | 0.06 |
| Stochastic Oscillator | 88.78 | 84.62 |
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).